Your browser doesn't support javascript.
loading
Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer.
Kim, Daniel W; Chen, Ming-Hui; Wu, Jing; Huland, Hartwig; Graefen, Markus; Tilki, Derya; D'Amico, Anthony V.
Afiliación
  • Kim DW; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.
  • Chen MH; Department of Statistics, University of Connecticut, Mansfield, Connecticut.
  • Wu J; University of Rhode Island, South Kingstown, Rhode Island.
  • Huland H; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Graefen M; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • D'Amico AV; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Cancer ; 127(13): 2222-2228, 2021 07 01.
Article en En | MEDLINE | ID: mdl-34101827
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article